Stockreport

Upstream Bio Presents New Structural Data on Verekitug, Highlights Unique TSLP Receptor Targeting [Yahoo! Finance]

Upstream Bio, Inc.  (UPB) 
PDF and mechanistic data for its therapeutic candidate, verekitug, at the European Respiratory Society/ERS Congress. The congress was held from September 27 – October 1 in A [Read more]